{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:39:55Z","timestamp":1791567595508,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001502","name":"India Department of Atomic Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejmech.2021.113516","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T11:54:49Z","timestamp":1620129289000},"page":"113516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Design, synthesis, in\u00a0vitro and in\u00a0vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents"],"prefix":"10.1016","volume":"221","author":[{"given":"Shachi","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7535-8846","authenticated-orcid":false,"given":"Naveen","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pragya","family":"Chandrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-7528","authenticated-orcid":false,"given":"Chandra Prakash","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajiya","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi P.","family":"Vats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-539X","authenticated-orcid":false,"given":"Susanta","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113516_bib1","first-page":"1","article-title":"The history of leishmaniasis","volume":"82","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejmech.2021.113516_bib2","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113516_bib3","first-page":"69","article-title":"Review of the current treatments for leishmaniases","volume":"3","author":"Lauletta","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"issue":"Suppl","key":"10.1016\/j.ejmech.2021.113516_bib4","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113516_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/B978-0-12-407679-2.00005-3","article-title":"Mechanisms of immune evasion in leishmaniasis","volume":"82","author":"Gupta","year":"2013","journal-title":"Adv. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113516_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/b416651p","article-title":"2-Pyrone natural products and mimetics: isolation, characterisation and biological activity","volume":"22","author":"McGlacken","year":"2005","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2021.113516_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1039\/np9931000071","article-title":"Microbial pyran-2-ones and dihydropyran-2-ones","volume":"10","author":"Dickinson","year":"1993","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2021.113516_bib8","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1016\/j.bmc.2004.01.051","article-title":"2-Pyrones possessing antimicrobial and cytotoxic activities","volume":"12","author":"Fairlamb","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib9","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1016\/S0960-894X(97)10153-6","article-title":"Synthesis of thiophenes and thieno[3, 2-c]pyran-4-ones as antileishmanial and antifungal agents","volume":"7","author":"Ram","year":"1997","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113516_bib10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ejmech.2017.08.055","article-title":"Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi","volume":"139","author":"Tempone","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0001-706X(02)00258-9","article-title":"Antileishmanial activity of two \u03b3-pyrones from Podolepsis hieracioides (Asteraceae)","volume":"86","author":"Kayser","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2021.113516_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejmech.2005.01.004","article-title":"Antileishmanial agents part-IV: synthesis and antileishmanial activity of novel terpenyl pyrimidines","volume":"40","author":"Chandra","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2004.01.009","article-title":"Piperazine-linked bisbenzamidines: a novel class of antileishmanial agents","volume":"39","author":"Mayence","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.ejmech.2008.03.039","article-title":"Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in\u00a0vitro biological evaluation","volume":"44","author":"Poorrajab","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib15","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1021\/acs.jmedchem.5b01456","article-title":"Novel amino-pyrazole ureas with potent in\u00a0vitro and in\u00a0vivo antileishmanial activity","volume":"58","author":"Mowbray","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib16","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/molecules16053469","article-title":"Thiophene derivatives with antileishmanial activity isolated from aerial parts of Porophyllum ruderale (Jacq.) Cass","volume":"16","author":"Takahashi","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113516_bib17","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1016\/j.tet.2009.06.031","article-title":"Natural and synthetic 2H-pyran-2-ones and their versatility in organic synthesis","volume":"65","author":"Goel","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113516_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113516_bib20","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"12","author":"Veber","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib21","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","article-title":"Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties","volume":"43","author":"Ertl","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113516_bib22","author":"Sander"},{"key":"10.1016\/j.ejmech.2021.113516_bib23","first-page":"1","volume":"vol. 2","author":"Gannavaram","year":"2012"},{"key":"10.1016\/j.ejmech.2021.113516_bib24","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/acs.jmedchem.9b00628","article-title":"Synthesis, biological evaluation, structure-activity relationship, and mechanism of action studies of quinoline-metronidazole derivatives against experimental visceral leishmaniasis","volume":"62","author":"Upadhyay","year":"2019","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421003652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:27:48Z","timestamp":1759328868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421003652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":23,"alternative-id":["S0223523421003652"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113516","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, in\u00a0vitro and in\u00a0vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113516"}}